Cancer, Therapy-Related Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting cancer, therapy-related clinical trials across 6 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Brampton, Ontario, Canada, Calgary, Alberta, Canada, Edmonton, Alberta, Canada. Updated daily from ClinicalTrials.gov.


Cancer, Therapy-Related Trials at a Glance

8 actively recruiting trials for cancer, therapy-related are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Brampton, Calgary, and Edmonton. Lead sponsors running cancer, therapy-related studies include Clinica Universidad de Navarra, Universidad de Navarra, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Chang Gung Memorial Hospital.

Browse cancer, therapy-related trials by phase

Treatments under study

About Cancer, Therapy-Related Clinical Trials

Looking for clinical trials for Cancer, Therapy-Related? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer, Therapy-Related trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer, Therapy-Related clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

A Longitudinal Photo-Narrative Exploration of Hope During Phase 1/2 Clinical Trials For Pediatric Cancer

Cancer, Therapy-Related
St. Jude Children's Research Hospital100 enrolled1 locationNCT07444216
Recruiting
Not Applicable

Exercise to ReGain Stamina and Energy (The EXERGISE Study)

Breast CancerFatigueCancer, Therapy-Related
University of Florida24 enrolled1 locationNCT05684367
Recruiting

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

CancerCancer, Therapy-RelatedRas (Kras or Nras) Gene Mutation+7 more
University Health Network, Toronto5,500 enrolled27 locationsNCT04151342
Recruiting

Proton Radiation Therapy Registry

Cancer, Therapy-Related
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5,000 enrolled4 locationsNCT04376229
Recruiting
Not Applicable

The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement

Cancer, Therapy-RelatedProbiotics
Chang Gung Memorial Hospital120 enrolled1 locationNCT06998823
Recruiting
Phase 4

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Breast CancerHeart FailureBreast Diseases+10 more
Silesian Centre for Heart Diseases600 enrolled4 locationsNCT05465031
Recruiting
Phase 3

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

Colorectal, CancerLiver MetastasesCirculating Tumor Cell+1 more
Sixth Affiliated Hospital, Sun Yat-sen University346 enrolled1 locationNCT05797077
Recruiting

Proton Therapy Medical Registry

Cancer, Therapy-Related
Clinica Universidad de Navarra, Universidad de Navarra6,000 enrolled2 locationsNCT05151952